According to our (Global Info Research) latest study, the global Pharmaceutical Grade Xanthan Gum market size was valued at US$ 59.67 million in 2025 and is forecast to a readjusted size of US$ 86.38 million by 2032 with a CAGR of 5.7% during review period.
Pharmaceutical Grade Xanthan Gum is a high-purity xanthan gum used as a pharmaceutical excipient in drug and healthcare formulations. It is a high-molecular-weight anionic polysaccharide produced by controlled microbial fermentation of carbohydrate substrates using Xanthomonas strains, followed by purification, drying and milling. Compared with ordinary food or industrial grades, pharmaceutical grade xanthan gum places greater emphasis on pharmacopoeial compliance, excipient GMP control, traceability, residual solvent control, microbial limits, heavy metal limits, batch-to-batch consistency and suitability for regulated dosage forms. Its main value in formulation is to provide viscosity control, suspension stability, emulsion stabilization, gel structure, mucoadhesion and controlled drug release.
In 2025, global sales of Pharmaceutical Grade Xanthan Gum reached approximately 13 K tons, with an average global market price of around US$ 4,607/ton. Production capacity varies significantly among manufacturers, with gross profit margins ranging from approximately 20% to 50%.
Pharmaceutical Grade Xanthan Gum is a natural-origin rheology modifier within the pharmaceutical excipient industry. Demand mainly comes from oral liquid formulations, controlled-release solid dosage forms, topical semi-solid products, dental preparations and dysphagia-related products. Compared with ordinary food-grade xanthan gum, its purchasing logic is closer to that of regulated pharmaceutical excipients. Customers assess not only viscosity, dispersibility and stability, but also pharmacopoeial compliance, GMP control, change management, impurity profile, microbial limits, residual solvents, supply continuity and dossier support. Therefore, competitive barriers are created not only by fermentation scale and cost, but also by quality systems, regulatory capability and long-term customer qualification.
The market outlook remains fundamentally stable. On one side, population ageing, improved convenience for pediatric and geriatric medication, and rising demand for liquid dosage forms and swallowing-friendly products support the use of xanthan gum in oral suspensions, syrups and thickened preparations. On the other side, natural-origin, non-animal, bio-based and biodegradable excipients are receiving greater attention, and xanthan gum continues to provide formulation value in controlled-release matrices, mucoadhesive systems, topical gels and emulsion stabilization. For high-end suppliers, multi-compendial compliance, low bioburden, low residual solvents, fast dispersibility and strong batch consistency are key factors for entering multinational pharmaceutical and CDMO supply chains.
However, the market also faces substitution and qualification barriers. HPMC, CMC, hydroxyethyl cellulose, alginates, carbomers, povidone, gelatin, pectin, guar gum and gellan gum can perform similar functions in different dosage forms. Once a pharmaceutical formulation is validated, customers usually avoid changing excipients, which lengthens the entry cycle for new suppliers. At the same time, pharmacopoeial updates, regulatory audits, raw material traceability, microbial control and residual solvent requirements continue to raise compliance costs. Future competition is expected to focus on regulatory documentation, quality consistency, global supply capability and application support for specific dosage forms.
This report is a detailed and comprehensive analysis for global Pharmaceutical Grade Xanthan Gum market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pharmaceutical Grade Xanthan Gum market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Pharmaceutical Grade Xanthan Gum market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Pharmaceutical Grade Xanthan Gum market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Pharmaceutical Grade Xanthan Gum market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharmaceutical Grade Xanthan Gum
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharmaceutical Grade Xanthan Gum market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Fufeng Group, CP Kelco, Deosen Biochemical, Jianlong Biotechnology, Jungbunzlauer, IFF, Hebei Xinhe Biochemical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Pharmaceutical Grade Xanthan Gum market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Powder
Liquid
Market segment by Clarity
Conventional
Clarified
Market segment by Viscosity
< 1,600 mPa·s
≥ 1,600 mPa·s
Market segment by Application
Oral Suspensions and Syrups
Controlled-Release Oral Solid Dosage Forms
Topical Semi-Solid Dosage Forms
Other
Major players covered
Fufeng Group
CP Kelco
Deosen Biochemical
Jianlong Biotechnology
Jungbunzlauer
IFF
Hebei Xinhe Biochemical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pharmaceutical Grade Xanthan Gum product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pharmaceutical Grade Xanthan Gum, with price, sales quantity, revenue, and global market share of Pharmaceutical Grade Xanthan Gum from 2021 to 2026.
Chapter 3, the Pharmaceutical Grade Xanthan Gum competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pharmaceutical Grade Xanthan Gum breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Pharmaceutical Grade Xanthan Gum market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pharmaceutical Grade Xanthan Gum.
Chapter 14 and 15, to describe Pharmaceutical Grade Xanthan Gum sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Pharmaceutical Grade Xanthan Gum. Industry analysis & Market Report on Pharmaceutical Grade Xanthan Gum is a syndicated market report, published as Global Pharmaceutical Grade Xanthan Gum Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Pharmaceutical Grade Xanthan Gum market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.